Ryan Schiller's questions to Embecta Corp (EMBC) leadership • Q1 2025
Question
Ryan Schiller from Wolfe Research asked for more details on Embecta's strategy to expand its product portfolio by distributing products for other companies. He sought to understand the specific types of products that would fit Embecta's commercial model and the potential timing for when these initiatives might begin contributing to financial results.
Answer
CEO Devdatt Kurdikar explained that the product strategy is tailored to leverage regional commercial strengths. For example, in China, they could add hospital-focused products; in the U.S. and parts of Europe, products fitting the retail pharmacy channel; and in Germany and Japan, products for endocrinologists. He stated that the company is actively working on adding these products and expects to provide more concrete examples and details at the upcoming Analyst Day in May 2025.